BrightHeart

Paris, France

BrightHeart focuses on enhancing prenatal ultrasound assessments through its B-Right AI Platform. The platform empowers clinicians and sonographers by facilitating comprehensive and standardized expert-level assessments during routine anatomy scans, addressing the complexities and inconsistencies prevalent in prenatal ultrasound evaluations. BrightHeart’s solutions aim to improve exam completeness, reduce errors in detection of congenital heart defects (CHDs), and optimize workflow through seamless integration with existing ultrasound equipment. With the mission of delivering expert-level ultrasound care worldwide, BrightHeart's technologies provide detailed evaluations of fetal heart structures, enabling early detection and management of congenital heart defects. Their products, B-Right Views and B-Right Screen, are both FDA-cleared Class II medical devices.